Dublin, Jan. 05, 2026 (GLOBE NEWSWIRE) -- The "Fill Finish Manufacturing Market - A Global and Regional Analysis: Focus on Product, End Users, and Region - Analysis and Forecast, 2025-2035" has been ...
—New service ensures rapid delivery of small volume clinical trial materials, solving a critical bottleneck in drug development— SPOKANE, Wash.--(BUSINESS WIRE)--Selkirk Pharma, Inc., a privately held ...
The "Fill Finish Pharmaceutical Contract Manufacturing Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Fill Finish Service Offered, Type of FDF, API Potency, Type of ...
Building a solid commercial drug strategy is centered on engaging partners strategically and at the earliest stage possible. Drug developers need partners with a wide range of experience that can ...
A booming biologics market is increasing demand for specialist fill-finish services and prompting contractors to invest in technologies that reduce waste and safeguard these sensitive medicines. The ...
Cell therapies such as CAR-T have revolutionized the biopharmaceutical industry, especially manufacturing processes. As a result, cell therapy developers are always searching for flexible solutions to ...
DUBLIN--(BUSINESS WIRE)--The "Fill Finish Manufacturing Market - A Global and Regional Analysis: Focus on Product, End Users, and Region - Analysis and Forecast, 2025-2035" report has been added to ...
Fill Finish Manufacturing Market worth $28.14 billion by 2030 with 8.9% CAGR | MarketsandMarkets(TM)
The MarketWatch News Department was not involved in the creation of this content. DELRAY BEACH, Fla., Aug. 19, 2025 /PRNewswire/ -- The global Fill Finish Manufacturing Market, valued at US$16.85 ...
SPOKANE, Wash.--(BUSINESS WIRE)--Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results